Tag Archives: FDA

Brain Cell Care After TBI

From Combat & Casualty Care, Q1 2019 Issue

A medical research company has shown an early signal of brain cell protection in traumatic brain injury (TBI) patients with its repurposed drug and is now progressing the preventive treatment program into advanced clinical trials.

By Steve Campbell, Campbell & Company Strategies Inc.


Wanted: Ebola Vaccine

Army’s Medical Research Institute of Infectious Diseases pitches in to stem the tide.

By Cheryl Pellerin, DoD News

During a recent interview, U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) scientists described their vaccine and drug-development research, development processes, and products in development for the Ebola virus and other infectious diseases. (more…)

Ebola Response: Detecting the Disease

Ebola virus particles

How existing and emerging technologies can help stop the spread of a worldwide epidemic.

By Steve Melito, S&BP Editor

In October, Liberian Thomas Eric Duncan became the first person to die of Ebola in the U.S. after medical staff at Texas Health Presbyterian hospital initially misdiagnosed his condition. Later that month, the Food and Drug Administration (FDA) authorized the emergency use of the Center for Disease Control’s (CDC) Ebola Virus VP40 Real-Time RT-PCR assay on the 7500 Fast Dx Real-Time PCR instrument from Applied Biosystems (ABI), Inc. This polymerase chain reaction (PCR) instrument uses real-time nucleic acid amplification and five-color fluorescence detection for in vitro diagnostic use.